Hepatitis Forums
Fatty Liver Disease Main Forums => Nonalcoholic Steatohepatitis (NASH) => Topic started by: Hep Editors on June 13, 2018, 10:12:11 am
-
Individuals with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH) see their health care costs rise dramatically after being diagnosed with compensated cirrhosis (the less severe form of the advanced liver disease), MedPage Today reports.
Researchers analyzed medical claims data from a German health care database covering 2011 to 2016. They identified individuals diagnosed with NAFLD/NASH and then determined whether they were later diagnosed with compensated cirrhosis. The study cohort members were characterized as “CC progressors” if they progressed to end-stage liver disease (ESLD) within one year of their cirrhosis diagnosis or “CC nonprogressors” if they did not progress to ESLD within that period.
Read more...
https://www.hepmag.com/article/costs-spike-treating-nafldnash-cirrhosis-diagnosis